Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN113666915B reveals a novel 5-step route for posaconazole intermediates using chiral iron catalysis, offering high purity and scalable manufacturing for global supply chains.
Patent CN102690223A reveals a cost-effective 7-step synthesis for 1-acetyl-7-cyano-5-(2-aminopropyl)indoline, offering significant supply chain advantages.
Novel non-enzymatic synthesis of niraparib intermediate via oxazolone route. High purity, scalable process offering significant cost reduction in API manufacturing.
Novel transfer hydrogenation process ensures safe scalable production of high-purity fluorescent tracers with reduced operational hazards and improved efficiency.
Patent CN112300122A details a mild synthesis route for triazole derivatives, offering cost reduction in API manufacturing and high-purity intermediates for global supply chains.
Patent CN115073422A reveals a high-yield 4-step route for 4-(1-methyl-1H-pyrazol-5-yl)piperidine, offering cost reduction in API manufacturing and reliable supply.
Patent CN118496218A reveals a novel carbazole-oxadiazole dual-target inhibitor with superior safety and efficacy for cost-effective diabetes pharmaceutical manufacturing.
Discover the scalable synthesis of CCR-2 antagonist intermediates via patent CN101160286B. Learn about cost-effective routes and high-purity pharmaceutical manufacturing.
Patent CN106432212B reveals a novel two-step synthesis for piribedil offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN1152865C details an optimized Celecoxib synthesis using in-situ catalysis and greener solvents, offering significant cost and safety advantages for API manufacturing.
Patent CN118894779A reveals continuous flow method for high-purity pharmaceutical intermediates. Reduces cost and improves supply chain reliability for CXCR7 antagonist production.
Patent CN116410186B reveals novel epipiprazole ester synthesis with faster metabolism. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN1247573C reveals a high-yield route for CDK inhibitor intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel iron-catalyzed oxidation route for biotin precursor keto acid improves yield and reduces waste for reliable pharmaceutical intermediates supplier.
Patent CN110776464B reveals green N1 alkylation method. Offers high yield, low toxicity, and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN112094212A reveals a robust method for 1-(mercaptomethyl)cyclopropylacetic acid, offering superior yield and purity for pharmaceutical supply chains.
Patent CN101671333B reveals a novel resin-based separation method for emtricitabine, ensuring high purity and cost-effective scale-up for global pharmaceutical manufacturers.
Discover the advanced resin adsorption process for Cefoxitin Sodium. Enhance purity and reduce manufacturing costs with our reliable pharmaceutical intermediate supply solutions.
Patent CN100334067C introduces a water-soluble scavenger for purifying amides and sulfonamides, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Discover the advanced 5-step synthesis of Allylestrenol (CAS 432-60-0) via Birch reduction. A cost-effective, scalable route for pharmaceutical intermediates ensuring high purity.